Evaluating thumbtack needle therapy for improving sleep and recovery after surgery
A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment
This study is testing if thumbtack needle therapy can help women recover better and sleep more soundly after breast cancer surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 110 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Sponsor | The First Affiliated Hospital of Xiamen University Academic / other |
| Locations | 2 sites (Xiamen, Fujian and 1 other locations) |
| Trial ID | NCT06757023 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the effectiveness of thumbtack needle therapy on postoperative sleep quality and recovery in patients who have undergone general anesthesia for breast cancer surgery. It will focus on understanding how this therapy can prevent sleep disorders and enhance recovery outcomes. The study will include women aged 18-55 who meet specific health criteria and will monitor their postoperative experiences. The findings could provide insights into alternative therapies for managing postoperative complications.
Who should consider this trial
Good fit: Ideal candidates are women aged 18-55 undergoing breast cancer surgery with general anesthesia and classified as ASA I-II.
Not a fit: Patients with severe underlying health conditions or a history of sleep disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve sleep quality and recovery times for postoperative patients.
How similar studies have performed: While the specific use of thumbtack needle therapy is novel, similar acupuncture approaches have shown promise in improving postoperative recovery in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients undergoing breast cancer surgery with general anesthesia in the hospital; 2. American Society of Anesthesiologists (ASA) classification I-II; 3. Women aged 18-55 years; 4. No history of chronic insomnia; 5. Individuals who have not taken sedative-hypnotic drugs within the past month. Exclusion Criteria: 1. Those who do not meet the aforementioned inclusion criteria; 2. A history of severe heart, brain, lung, or kidney diseases (such as acute coronary syndrome (ACS), severe heart failure classified as NYHA Class III or IV, severe arrhythmias, severe valvular disease; acute aortic disease, and severe peripheral vascular disease, etc.), or poor physical condition (including reduced exercise tolerance, multi-organ dysfunction, malnutrition, etc.); 3. A history of sleep disorders and psychiatric history; 4. Inability to receive thumb-tack needle treatment.
Where this trial is running
Xiamen, Fujian and 1 other locations
- First Affiliated Hospital of Xiamen University — Xiamen, Fujian, China (Recruiting)
- First Affiliated Hospital of Xiamen University — Xiamen, Fujian, China (Recruiting)
Study contacts
- Study coordinator: Bin Yang doctor
- Email: yangbin4332@outlook.com
- Phone: 1385998603
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.